SNAI2 and cholangiocarcinoma: Furthermore, CCAT2 demonstrates cross-cancer type EMT regulatory capabilities, regulating Snail2 expression in hepatocellular carcinoma [56], interacting with epigenetic factors EZH2, H3K27me3, and LSD1 in gastric cancer [57], and modulating EMT-related gene expression in CCA [58].